Refex Industries [REFEX] vs Soni Medicare [SML] Detailed Comparison

Refex Industries
NSE
Loading...

Soni Medicare
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Refex Industries wins in 10 metrics, Soni Medicare wins in 7 metrics, with 0 ties. Refex Industries appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Refex Industries | Soni Medicare | Better |
---|---|---|---|
P/E Ratio (TTM) | 33.57 | N/A | N/A |
Price-to-Book Ratio | 4.43 | 11.20 | Refex Industries |
Debt-to-Equity Ratio | 23.60 | 810.21 | Refex Industries |
PEG Ratio | 0.62 | N/A | N/A |
EV/EBITDA | 27.17 | 18.21 | Soni Medicare |
Profit Margin (TTM) | 6.43% | -0.60% | Refex Industries |
Operating Margin (TTM) | 9.22% | 7.28% | Refex Industries |
EBITDA Margin (TTM) | 9.22% | 7.28% | Refex Industries |
Return on Equity | 18.89% | -12.79% | Refex Industries |
Return on Assets (TTM) | 8.80% | 2.28% | Refex Industries |
Free Cash Flow (TTM) | $-4.75B | $8.76M | Soni Medicare |
1-Year Return | 67.18% | 109.09% | Soni Medicare |
Price-to-Sales Ratio (TTM) | 2.28 | 0.79 | Soni Medicare |
Enterprise Value | $53.87B | $230.56M | Refex Industries |
EV/Revenue Ratio | 2.18 | 0.74 | Soni Medicare |
Gross Profit Margin (TTM) | 9.33% | 53.06% | Soni Medicare |
Revenue per Share (TTM) | $201 | $124 | Refex Industries |
Earnings per Share (Diluted) | $12.39 | $-0.44 | Refex Industries |
Beta (Stock Volatility) | 2.28 | -0.40 | Soni Medicare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Refex Industries vs Soni Medicare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Refex Industries | -2.42% | -5.98% | -9.77% | -11.56% | -9.68% | -13.84% |
Soni Medicare | 1.99% | 1.67% | 15.50% | -10.89% | 50.04% | 68.61% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Refex Industries | 67.18% | 1,647.80% | 3,982.76% | 16,574.00% | 1,481.97% | 1,110.01% |
Soni Medicare | 109.09% | 157.85% | 58.84% | 259.15% | 259.15% | 259.15% |
Performance & Financial Health Analysis: Refex Industries vs Soni Medicare
Metric | REFEX | SML |
---|---|---|
Market Information | ||
Market Cap | ₹56.27B | ₹246.30M |
Market Cap Category | Mid cap | Small cap |
10 Day Avg. Volume | 258,301 | 1,877 |
90 Day Avg. Volume | 278,218 | 3,747 |
Last Close | ₹405.90 | ₹58.90 |
52 Week Range | ₹240.00 - ₹600.00 | ₹24.99 - ₹85.44 |
% from 52W High | -32.35% | -31.06% |
All-Time High | ₹600.00 (Sep 30, 2024) | ₹85.44 (May 05, 2025) |
% from All-Time High | -32.35% | -31.06% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.83% | 0.13% |
Quarterly Earnings Growth | 0.41% | 0.00% |
Financial Health | ||
Profit Margin (TTM) | 0.06% | -0.01% |
Operating Margin (TTM) | 0.09% | 0.07% |
Return on Equity (TTM) | 0.19% | -0.13% |
Debt to Equity (MRQ) | 23.60 | 810.21 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹93.88 | ₹5.16 |
Cash per Share (MRQ) | ₹29.51 | ₹7.98 |
Operating Cash Flow (TTM) | ₹-2,648,082,944 | ₹15.36M |
Levered Free Cash Flow (TTM) | ₹-4,132,273,408 | ₹-157,634 |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Refex Industries vs Soni Medicare
Metric | REFEX | SML |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 33.57 | N/A |
Forward P/E | N/A | N/A |
PEG Ratio | 0.62 | N/A |
Price to Sales (TTM) | 2.28 | 0.79 |
Price to Book (MRQ) | 4.43 | 11.20 |
Market Capitalization | ||
Market Capitalization | ₹56.27B | ₹246.30M |
Enterprise Value | ₹53.87B | ₹230.56M |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.18 | 0.74 |
Enterprise to EBITDA | 27.17 | 18.21 |
Risk & Other Metrics | ||
Beta | 2.28 | -0.40 |
Book Value per Share (MRQ) | ₹93.88 | ₹5.16 |
Financial Statements Comparison: Refex Industries vs Soni Medicare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | REFEX | SML |
---|---|---|
Revenue/Sales | ₹6.28B | ₹68.68M |
Cost of Goods Sold | ₹5.69B | ₹32.24M |
Gross Profit | ₹585.41M | ₹36.45M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹521.99M | ₹5.47M |
EBITDA | ₹379.04M | ₹6.96M |
Pre-Tax Income | ₹595.17M | ₹2.61M |
Income Tax | ₹115.96M | ₹-859,000 |
Net Income (Profit) | ₹479.22M | ₹3.47M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | REFEX | SML |
---|---|---|
Cash & Equivalents | ₹2.82B | ₹20.10M |
Total Current Assets | ₹13.11B | ₹137.75M |
Total Current Liabilities | ₹3.92B | ₹103.85M |
Long-Term Debt | ₹1.88B | ₹94.12M |
Total Shareholders Equity | ₹12.12B | ₹13.08M |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹228.04B | ₹60.31M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | REFEX | SML |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | REFEX | SML |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 258,301 | 1,877 |
Average Daily Volume (90 Day) | 278,218 | 3,747 |
Shares Outstanding | 129.18M | 4.26M |
Float Shares | 57.68M | 415,445 |
% Held by Insiders | 0.54% | 0.83% |
% Held by Institutions | 0.01% | 0.00% |
Dividend Analysis & Yield Comparison: Refex Industries vs Soni Medicare
Metric | REFEX | SML |
---|---|---|
Last 12-Month Dividend | ₹0.00 | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | ₹0.03 | N/A |
3-Year Avg Dividend Yield | 0.04% | N/A |
3-Year Total Dividends | ₹0.10 | N/A |
Ex-Dividend Date | Feb 20, 2024 | N/A |